Cargando…

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer

Pancreatic cancer (PC) is one of the deadliest malignancies. The high mortality rate of PC largely results from delayed diagnosis and early metastasis. Therefore, identifying novel treatment targets for patients with PC is urgently required to improve survival rates. A major barrier to successful tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wenhao, Qiu, Jiangdong, Zheng, Lianfang, Zhang, Taiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181875/ https://www.ncbi.nlm.nih.gov/pubmed/34158741 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.02.09

Ejemplares similares

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

Current epidemiology of pancreatic cancer: Challenges and opportunities
por: Luo, Wenhao, et al.
Publicado: (2020)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2022)

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
por: Wang, Ruobing, et al.
Publicado: (2022)

PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
por: Qiu, Jiangdong, et al.
Publicado: (2023)

MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
por: Zeng, Xue, et al.
Publicado: (2020)

Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients
por: Fu, Yibo, et al.
Publicado: (2022)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

Targeting the hypoxia pathway to treat pancreatic cancer
por: Erickson, Lori A, et al.
Publicado: (2015)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
por: Chen, Hao, et al.
Publicado: (2023)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
por: Zhu, Ruizhe, et al.
Publicado: (2020)

Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
por: Abou Khouzam, Raefa, et al.
Publicado: (2023)

Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
por: Luo, Wenhao, et al.
Publicado: (2022)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2021)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
por: Xu, Jianwei, et al.
Publicado: (2016)

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
por: Yang, Jinshou, et al.
Publicado: (2021)

CHIP: A new modulator of human malignant disorders
por: Cao, Zhe, et al.
Publicado: (2016)

Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy
por: Thirlwell, C, et al.
Publicado: (2011)

Targeted Therapies for Pancreatic Cancer
por: Amanam, Idoroenyi, et al.
Publicado: (2018)

Target c-Myc to treat pancreatic cancer
por: Ala, Moein
Publicado: (2022)

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer
por: Duffy, John P, et al.
Publicado: (2003)

The impact of hypoxia in pancreatic cancer invasion and metastasis
por: Yuen, Angela, et al.
Publicado: (2014)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
por: Kao, Ting-Wan, et al.
Publicado: (2023)

Biomarkers and Targeted Therapy in Pancreatic Cancer
por: Karandish, Fataneh, et al.
Publicado: (2016)

Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?
por: Feng, Mengyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e9rmm0huvpl24g284k2o9vrprv